Antihypertensive therapy: new pharmacological approaches.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000809:Angiotensins / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002216:Captopril / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008914:Minoxidil / Q000627:therapeutic use; D009126:Muscle Relaxation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D011224:Prazosin / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000809:Angiotensins; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D008914:Minoxidil; D002216:Captopril; D011224:Prazosin